ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

NMRA Neumora Therapeutics Inc

9.42
0.20 (2.17%)
Last Updated: 01:10:07
Delayed by 15 minutes

Period:

Draw Mode:

Volume 118,573
Bid Price 9.41
Ask Price 9.44
News -
Day High 9.66

Low
8.82

52 Week Range

High
21.00

Day Low 9.21
Share Name Share Symbol Market Stock Type
Neumora Therapeutics Inc NMRA NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.20 2.17% 9.42 01:10:07
Open Price Low Price High Price Close Price Previous Close
9.22 9.21 9.66 9.22
Trades Shares Traded VWAP Financial Volume Average Volume 52 Week Range
1,424 118,573 US$ 9.39 US$ 1,113,707 - 8.82 - 21.00
Last Trade Type Quantity Price Currency
01:10:07 100 US$ 9.42 USD

Neumora Therapeutics Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
1.5B 158.89M - 0 -235.93M -1.48 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Neumora Therapeutics News

Date Time Source News Article
15/4/202420:30GlobeNewswire Inc.Neumora Therapeutics Announces Clinical Hold of Phase 1..
13/3/202422:00GlobeNewswire Inc.Neumora Therapeutics to Participate at Stifel 2024 Virtual..
08/3/202408:34Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee..
07/3/202423:08Edgar (US Regulatory)Form 8-K - Current report
07/3/202423:00GlobeNewswire Inc.Neumora Therapeutics Reports Fourth Quarter and Full Year..
17/2/202408:21Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
17/2/202408:19Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
17/2/202408:14Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
17/2/202408:13Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
22/1/202423:00GlobeNewswire Inc.Neumora Therapeutics Appoints Kaya Pai Panandiker as Chief..
09/1/202400:32Edgar (US Regulatory)Form 8-K - Current report
02/1/202423:00GlobeNewswire Inc.Neumora Therapeutics to Present at 42nd Annual J.P. Morgan..

Historical NMRA Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week8.949.748.829.20588,8720.485.37%
1 Month13.8114.958.8211.07630,730-4.39-31.79%
3 Months17.7721.008.8213.68616,263-8.35-46.99%
6 Months10.8821.008.8213.88431,347-1.46-13.42%
1 Year16.5021.008.8213.46430,573-7.08-42.91%
3 Years16.5021.008.8213.46430,573-7.08-42.91%
5 Years16.5021.008.8213.46430,573-7.08-42.91%

Your Recent History

Delayed Upgrade Clock